Publications & Works

Publication Network
Articles 34
All (34)
SCI-E, SSCI, AHCI (27)
SCI-E, SSCI, AHCI, ESCI (27)
Scopus (27)
TRDizin (5)
Other Publications (3)

1. Surgical preference and outcomes in pilonidal sinus disease: a national multicenter study evaluating complications, recurrence, and quality of life (PISI TURKEY)

Yalcinkaya A., YALÇINKAYA A., Balci B., Sahin C., Ozeller E., Ozturk E., et al.
Techniques in Coloproctology , vol.30, no.1, 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

2. Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis

Gervais A., Marchal A., Boucherit S., Abi Haidar A., Bizien L., YALÇINKAYA A., et al.
The Journal of experimental medicine , vol.223, no.3, 2026 (SCI-Expanded, Scopus) identifier identifier

3. Evaluating IL1RA‐Autoantibodies Across SARS‐CoV‐2‐Related Diseases

Yalçinkaya A.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , vol.102, no.1, pp.5, 2025 (SCI-Expanded, Scopus) identifier identifier

4. Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination

Cavalli M., Eriksson N., Baron T., Yalcinkaya A., Landegren N., Brodin P., et al.
NPJ VACCINES , no.1, 2025 (SCI-Expanded, Scopus) identifier identifier

5. Immune dynamics throughout life in relation to sex hormones and perspectives gained from gender-affirming hormone therapy

Yalcinkaya A., Yalcinkaya R., Sardh F., Landegren N.
FRONTIERS IN IMMUNOLOGY , 2025 (SCI-Expanded, Scopus) identifier identifier

6. From RIFT Audit to RIFT Turkey: Reappraising Appendicitis Risk Models for Global Relevance

Yalcinkaya A., Yalçinkaya A., Leventoglu S.
Impact Surgery , vol.2, no.1, pp.1-4, 2025 (Peer-Reviewed Journal)

7. Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination

YALÇINKAYA A., Cavalli M., Aranda-Guillen M., Cederholm A., Guner A., Rietrae I., et al.
SCIENTIFIC REPORTS , vol.14, no.1, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

8. Nationwide prospective audit for the evaluation of appendicitis risk prediction models in adults: right iliac fossa treatment (RIFT)—Turkey

Yalcinkaya A., Yalçinkaya A., Balci B., Keskin C., Erkan I., Yildiz A., et al.
BJS OPEN , vol.8, no.5, pp.120, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

9. Plasma sphingolipids in patients with sickle cell disease: Multiple-site vaso-occlusive crises could be associated with lower sphingolipid levels.

Alp G., Oztas Y., Yalçinkaya A., Ozel S., Yildirim N., Unal S.
Lipids , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

10. No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines

Yalçinkaya A.
npj Vaccines , vol.9, no.42, pp.1-7, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

11. Sterols in Inflammatory Diseases: Implications and Clinical Utility.

Yalcinkaya A., Öztaş Y. E., Sabuncuoğlu S.
Advances in experimental medicine and biology , vol.1440, pp.261-275, 2024 (SCI-Expanded, Scopus) identifier identifier

12. Local excision versus thrombectomy in thrombosed external hemorrhoids: a multicenter, prospective, observational study

Yalcinkaya A., Yalçinkaya A., Atici S. D., Sahin C., Leventoglu S., Collaboration O. B. O. T. E. H. S.
BMC SURGERY , vol.23, pp.1-10, 2023 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

13. Nociceptive improvements and kynurenine pathway alterations with diclofenac treatment in a rat model of neuropathic pain created by partial sciatic nerve ligation

DEBBAĞ S., Yalcinkaya A., Saricaoglu F.
European review for medical and pharmacological sciences , vol.27, no.9, pp.4239-4247, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

14. The effect of silymarin given before partial hepatectomy on liver regeneration in rats with ischemic preconditioning during liver resection

Yalçinkaya A.
Archives of Current Medical Research , vol.0, no.0, 2022 (Peer-Reviewed Journal)

15. Possible Effect of Chelation Treatment on Metabolomic and Lipidomic Analysis in Lead Exposure

Çetin T., Samadi A., Reçber T., Dinçer A. K., Eser B., Yalcinkaya A., et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE , vol.64, no.5, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

16. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome

Yildirim N., ÜNAL S., Yalcinkaya A., Karahan F., ER ÖZTAŞ Y.
ANNALS OF HEMATOLOGY , vol.101, no.1, pp.35-41, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

17. Investigating the psychological impact of COVID-19 on healthcare workers in the intensive care unit

SÜNNETÇİ SİLİSTRE E., HATİPOĞLU H. U., YEŞİLBAŞ O., ŞÜKRÜ GÜRBÜZ F., ÖZTÜRK E., YALÇINKAYA A.
Journal of Surgery and Medicine , vol.6, 2022 (TRDizin) Creative Commons License Sustainable Development

18. RIFT Turkey: Right Iliac Fossa Treatment Audit Turkey

Yalçınkaya A., Balcı B., Leventoğlu Ö. S., Yıldız A., Kayacan G., Yalçınkaya A.
COLORECTAL DISEASE , vol.23, no.S2, pp.188-198, 2021 (SCI-Expanded, Scopus)

19. Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response

Vaena S., Chakraborty P., Lee H. G., Janneh A. H., Kassir M. F., Beeson G., et al.
CELL REPORTS , vol.35, no.5, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

20. A Comprehensive Review on Oxysterols and Related Diseases

Samadi A., SABUNCUOĞLU S., Samadi M., YILMAZ IŞIKHAN S., Chirumbolo S., Peana M., et al.
CURRENT MEDICINAL CHEMISTRY , vol.28, no.1, pp.110-136, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

21. Increasing the accuracy and reliability of the ninhydrin method of cyanide detection in human plasma

Öz E., Yalçınkaya A., Aktan O., Er Öztaş Y.
TURKISH JOURNAL OF BIOCHEMISTRY , vol.45, no.s2, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

22. Plasma Ceramides and Sphingomyelins of Pediatric Patients Increase in Primary Ciliary Dyskinesia but Decrease in Cystic Fibrosis

Bal T., Tugcu G., Ozcan F., Aslan M., Yalcinkaya A., Polat S., et al.
LIPIDS , vol.55, no.3, pp.213-223, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

23. Evaluation of oxysterol levels of patients with silicosis by LC-MS/MS method

Aksu N., Samadi A., Yalçınkaya A., Çetin T., Eser B., Lay İ., et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.467, pp.117-125, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

24. The increased neopterin content in turkish pediatric patients with sickle cell anemia

Sabuncuoğlu S., Öztaş Y., Yalçınkaya A., Ünal S., Baydar T., Girgin G.
Annals of Hematology , vol.99, no.1, pp.41-47, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

25. Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation.

Yalcinkaya A., Unal S., Oztas Y.
Lipids in health and disease , vol.18, pp.225, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

26. Treatment of thrombosed external hemorrhoids: comparison of the thrombectomy and local excision procedures in terms of results and outcome

Leventoğlu Ö. S., Yalçınkaya A., Kırımtay B., Yalçınkaya A.
COLORECTAL DISEASE , vol.21, no.S3, pp.131-133, 2019 (SCI-Expanded, Scopus)

27. Oxysterol concentrations are associated with cholesterol concentrations and anemia in pediatric patients with sickle cell disease

Yalcinkaya A., Samadi A., Lay İ., Unal S., Sabuncuoglu S., Oztas Y.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION , vol.79, no.6, pp.381-387, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

28. The serum leptin level in non-obese patients with obstructive sleep apnea.

Pamuk A. E., Süslü A., Yalçınkaya A., Öztaş Y., Pamuk G., Özer S., et al.
Auris, nasus, larynx , vol.45, no.4, pp.796-800, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

29. Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease

Yalcinkaya A., Unal S., Oztas Y.
Blood , vol.130, no.S1, pp.2240-2241, 2017 (SCI-Expanded, Scopus)

30. Increased plasma 7-ketocholesterol levels may explain the hypocholesterolemia of sickle cell disease patients

Yalçinkaya A., Samadi A., Lay I., Ünal S., Er Öztaş Y.
Febs Journal , vol.283, pp.64, 2017 (SCI-Expanded, Scopus)

31. Oxidative alterations in sickle cell disease: Possible involvement in disease pathogenesis

Er Öztaş Y., Yalçinkaya A.
World journal of Hematology , vol.6, no.3, pp.55-61, 2017 (Peer-Reviewed Journal)

32. Nursing Viewpoint: Toxicity Assessment in Patients Receiving Chemotherapy

Yalçinkaya A., Gümüşkaya G.
Acta Medica , vol.48, no.1, pp.1, 2017 (TRDizin) Creative Commons License

33. Hypocholesterolemia and increased plasma 7-ketocholesterol levels in pediatric Sickle Cell patients

Yalçinkaya A., Lay I., Samadi A., Ünal S., Akbiyik F., Er Öztaş Y.
Acta Medica , vol.48, pp.1-4, 2017 (TRDizin)

34. An overview of the significance of troponin in acute myocardial infarction

Yalçinkaya A., Er Öztaş Y.
Acta Medica , vol.46, no.1, pp.15-20, 2016 (TRDizin) Creative Commons License
Papers Presented at Peer-Reviewed Scientific Conferences 20

1. The Cytokine Profile of Primary Biliary Cholangitis (PBC): Is PBC an Autoinflammatory vs. Autoimmune Disease?

RADGOHAR A., ÜÇDAL M. T., BURUŞ A., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.
41. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 27 November 2024, (Summary Text)

2. POSSIBLE EFFECT OF CHELATION TREATMENT ON METABOLOMIC AND LIPIDOMIC ANALYSIS IN LEAD EXPOSURE

Çetin T., samadi a., REÇBER T., eser b., YALÇINKAYA A., ER ÖZTAŞ Y., et al.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Turkey, 22 - 25 June 2021, (Full Text)

3. Oxysterols may contribute to hemolysis in sickle cell disease

YALÇINKAYA A., Samadi A., LAY İ., ÜNAL S., SABUNCUOĞLU S., ER ÖZTAŞ Y.
44th FEBS CONGRESS, Krakow, Poland, 6 - 11 July 2019, vol.9, pp.69, (Summary Text)

4. Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease

YALÇINKAYA A., ÜNAL S., ER ÖZTAŞ Y.
59th ASH Annual Meeting and Expo, 9 - 12 December 2017, (Summary Text) identifier

5. Pediatrik Orak Hücre Hastalarında Sfingozin 1-fosfat Düzeyi

YALÇINKAYA A., ESER B., ÜNAL S., ER ÖZTAŞ Y.
II. Lipid Araştırmaları Çalıştayı, Ankara, Turkey, 07 October 2017, (Full Text)

6. THE ROLE OF ISCHEMIA MODIFIED ALBUMIN, 7-KETOCHOLESTEROL AND THE CHOLESTAN-3β,5α,6β-TRIOL IN THE DIAGNOSIS OF CORONARY ARTER DISEASE

KELEŞ M. E., YALÇINKAYA A., ŞENER Y. Z., SAMADİ A., SEZGİN A., CANPOLAT U., et al.
28th National Biochemistry Congress, Erzurum, Turkey, 19 - 23 September 2017, (Summary Text)

7. İnsan Serumunda Siyanür Ölçümü: Ninhidrin Yönteminin İki Farklı Uygulamasının Karşılaştırılması

YALÇINKAYA A., GÖK M., ER ÖZTAŞ Y.
Uluslarası Biyokimya Kongresi 2017/ 28. Ulusal Biyokimya Kongresi, Erzurum, Turkey, 19 - 23 September 2017, vol.42, pp.1-102, (Summary Text)

8. Increased 7-ketocholesterol in the plasma of pediatric Sickle Cell Disease patients.

YALÇINKAYA A., SAMADİ A., LAY İ., SABUNCUOĞLU S., ÜNAL S., ER ÖZTAŞ Y.
ENOR 7th Symposium. Oxysterols and sterol dervatives in health and disease., Brüksel, Belgium, 21 - 22 September 2017, (Summary Text)

9. Optimization and Use of the Ninhydrin Method of Cyanide Determination on Human Serum.

Yalçınkaya A., Gök M., Er Öztaş Y.
TBD Uluslararası Biyokimya Kongresi 2017, Erzurum, Turkey, 19 September 2017 - 23 September 2022, pp.156, (Full Text)

10. Koroner arter hastalığı tanısında iskemi modifiye albumin, 7-ketokolesterol ve kolestan 3β,5α,6β-triol’ün rolü.

KELEŞ M. E., YALÇINKAYA A., ŞENER Y. Z., SAMADİ A., SEZGİN A., CANPOLAT U., et al.
International Biochemistry Congress / 28th National Biochemistry Congress., Erzurum, Turkey, 19 - 23 September 2017, (Summary Text)

11. Altered neopterin levels in sickle cell anemia

SABUNCUOĞLU S., GİRGİN G., YALÇINKAYA A., ER ÖZTAŞ Y., ÜNAL S., BAYDAR T.
36th International Winter Workshop, 21 - 24 February 2017, (Summary Text)

12. Increased plasma 7-ketocholesterol levels may explain the hypocholesterolemia of sickle cell disease patients

Yalcinkaya A., Samadi A., Lay I., ÜNAL S., Akbiyik F., Oztas Y.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, pp.64, (Summary Text) identifier

13. Spgingosine 1 phosphate levels in the plasma of sickle cell anemia patients

YALÇINKAYA A., Eser B., ÜNAL S., GÜL H., ER ÖZTAŞ Y.
Gordon Research Conference-Glycolipid Sphingolipid Biology, 6 - 11 March 2016, (Summary Text)

14. Sphingosine 1 Phosphate Levels in the Plasma of Pediatric Sickle Cell Disease Patients

Yalçınkaya A., Eser B., Ünal S., Er Öztaş Y.
Gordon Research Conference on Glycolipid & Sphingolipid Biology 2016, Lucca, Italy, 6 - 11 March 2016, pp.23, (Full Text)

15. A reappraisal of Smedes method for lipid extraction in human serum

Yalçınkaya A., Er Öztaş Y.
5th European Lipidomics Meeting, Swansea, England, 01 January 2016, pp.1, (Summary Text)

16. A REAPPRAISAL OF SMEDES METHOD FOR LIPID EXTRACTION IN CLINICAL SAMPLES

YALÇINKAYA A., ER ÖZTAŞ Y.
5th European Lipidomic Meeting, 2 - 04 September 2015

17. ANALYSIS OF POLAR AND NONPOLAR LIPIDS IN THE SERUM OF RATS EXPOSED TO LOCAL RADIATION AND OZONE TREATMENT

ÖZTAŞ E., Gümüş R., Erdoğan E., YALÇINKAYA A., ER ÖZTAŞ Y., Kutlu A., et al.
5th European Lipidomic Meeting, 2 - 04 September 2015

18. Comparison of serum sphingosine 1 P levels among euthymic manic and depressive patients with bipolar disorders

ER ÖZTAŞ Y., YALÇINKAYA A., Serdar A., Eser B., SEMİZ M., Erdem M., et al.
International Ceramide Conference and Sphingolipid Club Joint Meeting, 6 - 10 May 2015

19. Comparision of Serum Sphingosine 1-Phosphate Levels Among Euthymic, Manic and Depressive Patients with Bipolar Disorder

Er Öztaş Y., Eser B., Yalçınkaya A.
International Ceramide Conference and Sphingolipid Club Joint Meeting 2015, İzmir, Turkey, 6 - 10 May 2015, pp.138, (Full Text) Creative Commons License

20. Bipolar bozukluğu olan ötimik manik ve depresif hastalarda serum protein oksidasyonunun karşılaştırılması

ER ÖZTAŞ Y., Serdar A., YALÇINKAYA A., BAL E. D., SEMİZ M., ERDEM M.
XV. Ulusal Klinik Biyokimya Kongresi, Muğla, Turkey, 23 - 26 April 2015
Books 6

1. Importance of Oxidative Stress and Antioxidant System in Health and Disease

Sabuncuoglu S. (Editor), Yalçinkaya A. (Editor)
IntechOpen, London, 2023

2. Sterols in Inflammatory Diseases: Implications and Clinical Utility

Yalçınkaya A., Er Öztaş Y., Sabuncuoğlu S.
in: Implication of Oxysterols and Phytosterols in Aging and Human Diseases, Wim E. Crusio,Haidong Dong,Heinfried H. Radeke,Nima Rezaei,Ortrud Steinlein,Junjie Xiao, Editor, Springer Nature, New York, pp.261-275, 2023

3. Lipit Araştırmalarının Geçmişi ve Geldiği Son Nokta: Lipidomik Araştırma Teknikleri

Öz E., Yalçinkaya A., Er Öztaş Y.
in: Health Science Research: Basic Medicine, Hülya Çiçek, Editor, Özgür Egitim Yayıncılık, Ankara, pp.13-35, 2023 Sustainable Development

4. Temel ve Klinik Biyokimyanın İlkeleri

YALÇINKAYA A., ÇİÇEK Ç., ARMUTCU ÇORMAN C., ÖZCAN M., ÇAKIR AKTAŞ C., GÖK M.
Dünya Tıp Kitabevi, Ankara, 2022

5. Lipidler ve Lipid Metabolizması

YALÇINKAYA A.
in: Temel ve Klinik Biyokimyanın İlkeleri, Çiçek Çiğdem, Yalçınkaya Ahmet, Editor, Dünya Tıp Kitabevi, Ankara, pp.79-106, 2022

6. Hormonlar ve Görevleri

YALÇINKAYA A.
in: Temel ve Klinik Biyokimyanın İlkeleri, Çiçek Çiğdem, Yalçınkaya Ahmet, Editor, Dünya Tıp Kitabevi, Ankara, pp.151-174, 2022
Metrics

Publication

60

Publication (WoS)

29

Publication (Scopus)

27

Citation (WoS)

257

H-Index (WoS)

7

Citation (Scopus)

174

H-Index (Scopus)

6

Citation (Scholar)

360

H-Index (Scholar)

10

Citation (Sobiad)

17

H-Index (Sobiad)

1

Citation (Sum Other)

94

Total Citation Count

391

Project

8

Open Access

8
UN Sustainable Development Goals